Activity
-
http://bit.ly/3Ldw0O0 Incredibly excited that Cartesian's Ph2b RCT was positive! Absolutely beautiful data from this first ever RCT of an engineered…
http://bit.ly/3Ldw0O0 Incredibly excited that Cartesian's Ph2b RCT was positive! Absolutely beautiful data from this first ever RCT of an engineered…
Shared by Murat Kalayoglu
-
This past week, Ark Clinical Research attended the World Vaccine conference in Washington DC. It was great to see Studykik's growth and contribution…
This past week, Ark Clinical Research attended the World Vaccine conference in Washington DC. It was great to see Studykik's growth and contribution…
Liked by Murat Kalayoglu
-
We’re excited to kick-off American Academy of Neurology’s #AANAM! Come check out Cartesian’s booth #735, and learn more about our approach to mRNA…
We’re excited to kick-off American Academy of Neurology’s #AANAM! Come check out Cartesian’s booth #735, and learn more about our approach to mRNA…
Liked by Murat Kalayoglu
More activity by Murat
-
Great victory in myeloma today: ODAC voted 12-0 for MRD as an early endpoint for accelerated approval in multiple myeloma! This will enable faster…
Great victory in myeloma today: ODAC voted 12-0 for MRD as an early endpoint for accelerated approval in multiple myeloma! This will enable faster…
Liked by Murat Kalayoglu
-
We are thrilled to be expanding at Ice Cream Jubilee to bring more delicious treats to our amazing customers in the DMV
We are thrilled to be expanding at Ice Cream Jubilee to bring more delicious treats to our amazing customers in the DMV
Liked by Murat Kalayoglu
-
I'm thrilled to announce that I've joined Icario as the Chief Commercial Officer leading account management, sales and marketing. I'm honored to…
I'm thrilled to announce that I've joined Icario as the Chief Commercial Officer leading account management, sales and marketing. I'm honored to…
Liked by Murat Kalayoglu
-
https://bit.ly/49BrRyo Thrilled that Cartesian just merged with Selecta to create a fully integrated, publicly traded company pioneering RNA cell…
https://bit.ly/49BrRyo Thrilled that Cartesian just merged with Selecta to create a fully integrated, publicly traded company pioneering RNA cell…
Shared by Murat Kalayoglu
-
The Economist just ran a story on our new clinical trial results for #myastheniagravis Cartesian Therapeutics https://lnkd.in/eqUS_KnK
The Economist just ran a story on our new clinical trial results for #myastheniagravis Cartesian Therapeutics https://lnkd.in/eqUS_KnK
Liked by Murat Kalayoglu
-
Here's a link to our paper in The Lancet Neurology on our prospective Phase 1b/2a study of RNA-modified rCAR-T cells for #myastheniagravis . We…
Here's a link to our paper in The Lancet Neurology on our prospective Phase 1b/2a study of RNA-modified rCAR-T cells for #myastheniagravis . We…
Liked by Murat Kalayoglu
-
https://lnkd.in/eaugCG-d - Grateful to my incredible colleagues at Cartesian Therapeutics, our dedicated investigators, and most of all our amazing…
https://lnkd.in/eaugCG-d - Grateful to my incredible colleagues at Cartesian Therapeutics, our dedicated investigators, and most of all our amazing…
Shared by Murat Kalayoglu
-
I am thrilled to announce that this June I will be joining the Cartesian Therapeutics R&D team as a Clinical Research Associate. I am excited to dive…
I am thrilled to announce that this June I will be joining the Cartesian Therapeutics R&D team as a Clinical Research Associate. I am excited to dive…
Liked by Murat Kalayoglu
-
We are excited to add Alto Neuroscience, an innovative company pioneering precision psychiatry, to our growing portfolio. Today Alto announced the…
We are excited to add Alto Neuroscience, an innovative company pioneering precision psychiatry, to our growing portfolio. Today Alto announced the…
Liked by Murat Kalayoglu
-
One patient's experience with our Descartes-08 RNA cell therapy was recently covered by the Myasthenia Gravis Foundation of America, Inc. in their…
One patient's experience with our Descartes-08 RNA cell therapy was recently covered by the Myasthenia Gravis Foundation of America, Inc. in their…
Liked by Murat Kalayoglu
-
GeneTherapyLive spoke with Cartesian's Michael Singer, CSO, to learn more about the advantages of mRNA-modified CAR T products over DNA-modified…
GeneTherapyLive spoke with Cartesian's Michael Singer, CSO, to learn more about the advantages of mRNA-modified CAR T products over DNA-modified…
Liked by Murat Kalayoglu
-
You've met Moderna, BioNTech and Curevac. Now meet Kernal Biologics, Inc. , the startup working on mRNA 2.0 https://lnkd.in/dwUVHTC
You've met Moderna, BioNTech and Curevac. Now meet Kernal Biologics, Inc. , the startup working on mRNA 2.0 https://lnkd.in/dwUVHTC
Liked by Murat Kalayoglu
-
NOW IN CLINICAL TRIALS: Cartesian announces the first mRNA-modified cell therapy for #COVID19 and #ARDS. Developed in record time with the RNA…
NOW IN CLINICAL TRIALS: Cartesian announces the first mRNA-modified cell therapy for #COVID19 and #ARDS. Developed in record time with the RNA…
Liked by Murat Kalayoglu
-
So proud of my Cartesian colleagues for the incredible work they've done in bringing the first RNA-engineered cell therapy for #ARDS and #COVID19…
So proud of my Cartesian colleagues for the incredible work they've done in bringing the first RNA-engineered cell therapy for #ARDS and #COVID19…
Shared by Murat Kalayoglu
Other similar profiles
-
Carsten Brunn
Connect -
Metin K.
Chief Technology Officer at Cartesian Therapeutics
Connect -
Christopher M. Jewell
Chief Scientific Officer, Cartesian Therapeutics | MPower Professor and Institute Professor of Translational Engineering | Biotechnology Consultant
Connect -
Milos Miljkovic
Connect -
Emily English
Connect -
Hafsa Kamboh
Director, Clinical Operations
Connect -
Kristen Baldwin
Connect -
Catherine Vesey
Connect -
Matt Duvernay
Connect -
Minhtran Casi
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More